Picard Medical Board Chairman issues letter to stockholders under Regulation FD

Picard Medical filed an 8-K to disclose that Board Chairman Richard Fang issued a letter to stockholders on May 29, 2026. The communication was made public through a press release under Regulation FD, which requires companies to broadly disseminate material information rather than selectively disclosing it to certain investors or analysts.

This suggests the Chairman's message may contain information the company considers significant enough to warrant formal disclosure. However, the 8-K itself provides no details about what the letter actually says. The content is referenced as an attached exhibit but not summarized in the filing body.

For retail investors, this creates an information gap—the filing signals that something noteworthy was communicated, but you'll need to locate and read the actual press release to understand what the Chairman said and why it matters. Watch for the full press release on the company's investor relations website or newswires to assess whether the letter addresses strategy changes, financial outlook, governance matters, or other material topics.